Clinical Trial
Candicidin for vaginal candidiasis
- PMID: 4567568
Item in Clipboard
Clinical Trial
Candicidin for vaginal candidiasis
Med Lett Drugs Ther.
.
Abstract
PIP: Candicidin for treatment of vaginal candidiasis is discussed. Candicidin has not been established as being superior to nystatin for cure or relief of monilial vaginal infections. Since nystatin has been in use for years with only minor adverse affect and since it is less exp ensive than candicidin, it should still be the drug of choice. If 1 or 2 courses of intravaginal and oral nystatin fail to cure (as tested by culture), candicidin is worth trying. Unlike mystatin, candicidin is not available in an oral formulation. Many "Medical Letter" consultants believe that cur of vaginal candidiasis is easier if patients stop taking oral contraceptives when the diagnosis is made.
Similar articles
-
Comparative evaluation of Monistat and Mycostatin in the treatment of vulvovaginal candidiasis.Obstet Gynecol. 1974 Sep;44(3):403-6. Obstet Gynecol. 1974. PMID: 4604245 Clinical Trial. No abstract available.
-
[New study shows probiotics ineffective in prevention of post-antibiotic vaginal candidiasis].Praxis (Bern 1994). 2004 Oct 27;93(44):1 p following 1843. Praxis (Bern 1994). 2004. PMID: 15559911 German. No abstract available.
-
Candicidin tablets and ointment in treatment of candidal vaginitis.N Y State J Med. 1975 Aug;75(9):1443-5. N Y State J Med. 1975. PMID: 1057063 No abstract available.
-
One-day therapy for vaginal candidiasis. A review.J Reprod Med. 1999 Jun;44(6):543-7. J Reprod Med. 1999. PMID: 10394549 Review.
-
Managing patients with vulvovaginal candidiasis.Nurse Pract. 1998 Mar;23(3):44-6,49-53. Nurse Pract. 1998. PMID: 9560829 Review.